Suppr超能文献

使用抗体-蓖麻毒素A链偶联物从人骨髓中清除肿瘤性B细胞。

Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow.

作者信息

Muirhead M, Martin P J, Torok-Storb B, Uhr J W, Vitetta E S

出版信息

Blood. 1983 Aug;62(2):327-32.

PMID:6409188
Abstract

Affinity-purified rabbit antibody to human lambda and kappa chains (R alpha H lambda kappa) was conjugated to the A-chain of the plant toxin, ricin. The resulting immunotoxin (R alpha H lambda kappa-A) killed cells from the tumor cell line Daudi, which bears surface immunoglobulin, but was nontoxic to the CFU-E, BFU-E, and CFU-GM of human bone marrow. R alpha H lambda kappa-A eliminated 99% of clonogenic Daudi cells that had been mixed with marrow cells in vitro, without demonstrable toxicity to hematopoietic cells. Thus, in vitro treatment of marrow with R alpha H lambda kappa-A may increase the incidence of cure following autologous bone marrow transplantation for the treatment of human B-cell malignancies.

摘要

将亲和纯化的抗人λ和κ链兔抗体(RαHλκ)与植物毒素蓖麻毒蛋白的A链偶联。所得免疫毒素(RαHλκ-A)可杀死携带表面免疫球蛋白的肿瘤细胞系Daudi的细胞,但对人骨髓的CFU-E、BFU-E和CFU-GM无毒。RαHλκ-A在体外消除了99%与骨髓细胞混合的克隆性Daudi细胞,对造血细胞无明显毒性。因此,用RαHλκ-A体外处理骨髓可能会提高自体骨髓移植治疗人类B细胞恶性肿瘤后的治愈率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验